Koronis Biomedical Technologies Osseo, MN - 55369

Koronis Biomedical Technologies is categorized under Health Services in Osseo, MN and active since 2010.

Koronis Biomedical Technologies was established in 2010, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Health Services business, which does work in the B2C market, and is classified as a Health Services, under code number 621999 by the NAICS.

If you are seeking more information, feel free to contact Pat Lichter at the company’s single location by writing to 6901 East Fish Lake Road, Osseo, Minnesota MN 55369 or by phoning (763) 447-6115. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Koronis Biomedical Technologies
Contact Person: Pat Lichter
Address: 6901 East Fish Lake Road, Osseo, Minnesota 55369
Phone Number: (763) 447-6115
Website Address: koronisbiotech.com
Annual Revenue (USD): $100.000 to $499.999
Founded: 2010
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Health Services
SIC Code: 8099
NAICS Code: 621999
Share This Business:

Koronis Biomedical Technologies was started in 2010 to provide professional Health Services under the SIC code 8099 and NAICS code 621999. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.

Feel free to contact Pat Lichter for inquiries that concern Koronis Biomedical Technologies by calling the company number (763) 447-6115, as your correspondence is most welcome. Additionally, the physical location of the single location of Koronis Biomedical Technologies can be found at the coordinates 45.08056,-93.446472 as well as the street address 6901 East Fish Lake Road in Osseo, Minnesota 55369.

For its online presence, you may visit Koronis Biomedical Technologies’s website at koronisbiotech.com and engage with its social media outlets through on Twitter and on Facebook.